BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26471812)

  • 1. Clinical utility of genetic variants of glutamate carboxypeptidase II in predicting breast cancer and prostate cancer risk.
    Naushad SM; Shree Divyya P; Janaki Ramaiah M; Alex Stanley B; Prasanna Lakshmi S; Vishnupriya J; Kutala VK
    Cancer Genet; 2015 Nov; 208(11):552-8. PubMed ID: 26471812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of glutamate carboxypeptidase II (GCPII) haplotypes with breast and prostate cancer risk.
    Divyya S; Naushad SM; Addlagatta A; Murthy PV; Reddy ChR; Digumarti RR; Gottumukkala SR; Subbarao SA; Kutala VK
    Gene; 2013 Mar; 516(1):76-81. PubMed ID: 23266799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical role of C1561T glutamate carboxypeptidase II (GCPII) genetic polymorphism in altering disease susceptibility.
    Divyya S; Naushad SM; Addlagatta A; Murthy PV; Reddy ChR; Digumarti RR; Gottumukkala SR; Kumar A; Rammurti S; Kutala VK
    Gene; 2012 Apr; 497(2):273-9. PubMed ID: 22310383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate carboxypeptidase II (GCPII) genetic variants as determinants of hyperhomocysteinemia: implications in stroke susceptibility.
    Divyya S; Naushad SM; Kaul S; Anusha V; Subbarao SA; Kutala VK
    Indian J Biochem Biophys; 2012 Oct; 49(5):356-62. PubMed ID: 23259322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel PSMA/GCPII-deficient mouse model shows enlarged seminal vesicles upon aging.
    Vorlová B; Sedlák F; Kašpárek P; Šrámková K; Malý M; Zámečník J; Šácha P; Konvalinka J
    Prostate; 2019 Feb; 79(2):126-139. PubMed ID: 30256431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.
    Evans JC; Malhotra M; Cryan JF; O'Driscoll CM
    Br J Pharmacol; 2016 Nov; 173(21):3041-3079. PubMed ID: 27526115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and biochemical characterization of the folyl-poly-γ-l-glutamate hydrolyzing activity of human glutamate carboxypeptidase II.
    Navrátil M; Ptáček J; Šácha P; Starková J; Lubkowski J; Bařinka C; Konvalinka J
    FEBS J; 2014 Jul; 281(14):3228-42. PubMed ID: 24863754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GCPII imaging and cancer.
    Foss CA; Mease RC; Cho SY; Kim HJ; Pomper MG
    Curr Med Chem; 2012; 19(9):1346-59. PubMed ID: 22304713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GCPII modulates oxidative stress and prostate cancer susceptibility through changes in methylation of RASSF1, BNIP3, GSTP1 and Ec-SOD.
    Divyya S; Naushad SM; Murthy PV; Reddy ChR; Kutala VK
    Mol Biol Rep; 2013 Oct; 40(10):5541-50. PubMed ID: 23979608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Looking for Drugs in All the Wrong Places: Use of GCPII Inhibitors Outside the Brain.
    Vornov JJ; Peters D; Nedelcovych M; Hollinger K; Rais R; Slusher BS
    Neurochem Res; 2020 Jun; 45(6):1256-1267. PubMed ID: 31749072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and quantitation of glutamate carboxypeptidase II in human blood.
    Knedlík T; Navrátil V; Vik V; Pacík D; Šácha P; Konvalinka J
    Prostate; 2014 May; 74(7):768-80. PubMed ID: 24647901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy.
    Tolkach Y; Gevensleben H; Bundschuh R; Koyun A; Huber D; Kehrer C; Hecking T; Keyver-Paik MD; Kaiser C; Ahmadzadehfar H; Essler M; Kuhn W; Kristiansen G
    Breast Cancer Res Treat; 2018 Jun; 169(3):447-455. PubMed ID: 29455299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico approaches to identify the potential inhibitors of glutamate carboxypeptidase II (GCPII) for neuroprotection.
    Naushad SM; Janaki Ramaiah M; Stanley BA; Prasanna Lakshmi S; Vishnu Priya J; Hussain T; Alrokayan SA; Kutala VK
    J Theor Biol; 2016 Oct; 406():137-42. PubMed ID: 27430729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity.
    Barinka C; Sácha P; Sklenár J; Man P; Bezouska K; Slusher BS; Konvalinka J
    Protein Sci; 2004 Jun; 13(6):1627-35. PubMed ID: 15152093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Label-free determination of prostate specific membrane antigen in human whole blood at nanomolar levels by magnetically assisted surface enhanced Raman spectroscopy.
    Chaloupková Z; Balzerová A; Bařinková J; Medříková Z; Šácha P; Beneš P; Ranc V; Konvalinka J; Zbořil R
    Anal Chim Acta; 2018 Jan; 997():44-51. PubMed ID: 29149993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parallel Metabolomics and Lipidomics of a PSMA/GCPII Deficient Mouse Model Reveal Alteration of NAAG Levels and Brain Lipid Composition.
    Sedlák F; Kvasnička A; Marešová B; Brumarová R; Dobešová D; Dostálová K; Šrámková K; Pehr M; Šácha P; Friedecký D; Konvalinka J
    ACS Chem Neurosci; 2024 Apr; 15(7):1342-1355. PubMed ID: 38377674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of glutamate carboxypeptidase II in human brain.
    Sácha P; Zámecník J; Barinka C; Hlouchová K; Vícha A; Mlcochová P; Hilgert I; Eckschlager T; Konvalinka J
    Neuroscience; 2007 Feb; 144(4):1361-72. PubMed ID: 17150306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Prostate-specific Membrane Antigen (PSMA/FOLH1) Expression in a Genomic Database.
    Bahler CD; Johnson MM; Davicioni E; Zhang J; Cheng L; Green MA; Koch MO
    Urology; 2020 Oct; 144():117-122. PubMed ID: 32619596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
    Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
    Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Missense Mutation in FOLH1 With Decreased NAAG Levels and Impaired Working Memory Circuitry and Cognition.
    Zink CF; Barker PB; Sawa A; Weinberger DR; Wang M; Quillian H; Ulrich WS; Chen Q; Jaffe AE; Kleinman JE; Hyde TM; Prettyman GE; Giegerich M; Carta K; van Ginkel M; Bigos KL
    Am J Psychiatry; 2020 Dec; 177(12):1129-1139. PubMed ID: 33256444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.